Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868618847Aexternal-prioritypatent/GB8618847D0/en
Application filed by Smith Kline French LabfiledCriticalSmith Kline French Lab
Publication of MX9203545ApublicationCriticalpatent/MX9203545A/en
Publication of MX174642BpublicationCriticalpatent/MX174642B/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere a una composición farmaceutica estable adecuada para administración oral que comprende una suspensión de cimetidina en partículas en una base acuosa teniendo un pH de por lo menos 7, un agente de suspensión con y, opcionalmente, excipientes adicionalmente farmaceuticos, en donde substancialmente toda la cimetidina presente es de la forma B polimórfica.The present invention relates to a stable pharmaceutical composition suitable for oral administration comprising a suspension of particulate cimetidine in an aqueous base having a pH of at least 7, a suspending agent with and, optionally, additionally pharmaceutical excipients, wherein Substantially all of the cimetidine present is of the polymorphic B form.
USE OF 5'-DEOXI-5'-METHYL-THIOADENOSINE, S-ADENOSYLMETIONINE AND ITS SALTS FOR THE PREPARATION OF REDUCING PHARMACEUTICAL COMPOSITIONS OF SEBORRHEA.